Page 1

1. Results ( July 2020 to June 2021 ) ( 1 ) Sales Sales totaled JPY 70.2B ( up 27.6B YoY ) 113.3 % progress vs. 62.0B forecast of sales for FY2021 ● Lasertec Corporation ( 6920 ) Fiscal Year ended June 2021 - 1on1 FAQ → MATRICS Series delivered , installed , and sold at a faster than expected pace " Semiconductor - related products " accounted for 58.4B ( up 24.0B YOY ) → A new categorization will be introduced to the breakdown of " semiconductor - related products " from FY2022 . For FY2021 , breakdown is presented in both old and new categorizations . → Old breakdown : EUV < 65 % , MATRICS > 15 % , MAGICS 10 % , other new products < 10 % → New breakdown : Mask inspection > 65 % , Blank inspection 25 % , Wafer inspection < 10 % " Other products " accounted for 3.6B ( up 1.4B YoY ) → Breakdown : FPD 70 % , microscopes and others 30 % " Services " accounted for 8.2B ( up 2.1B YoY ) ← ( 2 ) Orders Gross profit amounted to 36.9B ( up 13.9B YoY ) , and GP margin 52.6 % ( -1.4 % YoY ) Favorable change in product mix due to products with higher GP margins sold at a faster than expected pace Operating profit amounted to 26.0B ( up 11.0B YoY ) , and OP margin 37.1 % ( + 1.7 % YoY ) → OP margin rose due to increased GP and delay in R & D spending Net profit amounted to 19.2B ( up 8.4B YoY ) , and NP margin 27.4 % ( + 2.0 % YoY ) August 6 , 2021 ( 3 ) Income statement Orders totaled 112.9B ( up 32.7B YoY ) , and backlog at the end of the period amounted to 135.8B ( up 42.6B YoY ) → 118.8 % progress vs. 95.0B forecast of orders for FY2021 → Better result than forecast , driven by EUV - related systems , while orders for MATRICS ( for DUV masks ) also strong " Semiconductor - related products " accounted for 103.5B ( up 33.4B YoY ) → Old breakdown : EUV > 75 % , MATRICS < 15 % , MAGICS < 5 % , other new products > 5 % → New breakdown : Mask inspection > 80 % , Blank inspection < 15 % , Wafer inspection 5 % " Other products " accounted for < 0.9B ( down 2.6B YoY ) → Breakdown : FPD 5 % , microscopes and others 95 % " Services " accounted for 8.4B ( up 1.9B YoY ) R & D expenses amounted to 5.7B , 8.1 % of sales ( up 2.4B YoY ) → 92.6 % progress vs. 6.1B forecast of R & D expenses for FY2021 → Highest ever level of R & D spending , albeit less than forecast Depreciation and amortization amounted to 1.6B ( up 0.8B YoY ) 125.7 % progress vs. 1.3B forecast of depreciation and amortization for FY2021 Capital expenditure amounted to 5.7B ( up 4.6B YoY ) → 168.4 % progress vs. 3.4B forecast of capital expenditure for FY2021 1